Where Do SGLT-2s Fit in the Treatment of Diabetes? episode artwork

EPISODE · Oct 28, 2010 · 14 MIN

Where Do SGLT-2s Fit in the Treatment of Diabetes?

from Diabetes Discourse

Host: Steven Edelman, MD Guest: Robert Henry, MD The potential benefits of a new class of medications, sodium-dependent glucose cotransporter-2 therapy (or SGLT-2s), for type 2 diabetes is promising, but where will they fit in the treatment of diabetes and what are the risks? Join host Dr. Steven Edelman and his guest, professor of medicine at the Veterans Affairs Medical Center in San Diego, California, Dr. Robert Henry, as they discuss the mechanism, benefits and potential cardiovascular risks of this new class of medication.

Episode metadata supplied by the publisher feed · Published Oct 28, 2010

Embed this episode

NOW PLAYING

Where Do SGLT-2s Fit in the Treatment of Diabetes?

0:00 14:59

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Diabetes Discourse?

This episode is 14 minutes long.

When was this Diabetes Discourse episode published?

This episode was published on October 28, 2010.

Can I download this Diabetes Discourse episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!